Case Series to Evaluate the Efficacy of Selected Treatment Modality in the Management of VÄ tarakta (Gouty Arthritis)

Samaranayaka Liyanage Gayani Sewwandi, Fathima Shazmin Hazari and Mallawa Arachchige Maheshi Sandunika
Additional contact information
Samaranayaka Liyanage Gayani Sewwandi: Temporary demonstrator, Department of Cikitsa, Faculty of Indigenous Medicine, Gampaha Wickramarachchi University of Indigenous Medicine, Yakkala, Sri Lanka
Fathima Shazmin Hazari: Temporary demonstrator, Department of Cikitsa, Faculty of Indigenous Medicine, Gampaha Wickramarachchi University of Indigenous Medicine, Yakkala, Sri Lanka
Mallawa Arachchige Maheshi Sandunika: Temporary demonstrator, Department of Cikitsa, Faculty of Indigenous Medicine, Gampaha Wickramarachchi University of Indigenous Medicine, Yakkala, Sri Lanka

International Journal of Research and Scientific Innovation, 2023, vol. 10, issue 11, 311-318

Abstract: VÄ tarakta is a more common and distressing metabolic condition that exists nowadays. Rakta (blood) is the major DÅ«shya (vitiated) in VÄ tapradhÄ na (predominance of VÄ ta), TridÅ shaja (three body humors), and VÄ tavyÄ dhi (disease of VÄ ta). VÄ tarakta is a condition in which VÄ ta, a prominent DÅ sha, is unduly worsened by vitiated Rakta. Gout and VÄ tarakta are associated in modern science. Gout is a purine metabolic disorder that results in hyperuricemia and the development of monosodium urate crystals in joints. Gout’s primary symptom is pain, which interferes with sufferers’ daily lives. The purpose of this study is to determine the efficacy of a selected treatment modality in the management of VÄ tarakta. Three case presentations with a follow-up period of one month were studied. Treatment modality including Sinhasya PanchamÅ«li PhÄ nta, ChadraprabhÄ Vati, Nawarathna Kalka, ThriphalÄ ChÅ«rna, Pinda Thaila, and Nadi SwÄ“da was advised for four months along with Pathya Apathya (wholesome and unwholesome). Pre- and post-treatment assessments of subjective criteria were made. According to the results, the symptoms were reduced by 25%, 33.33%, 50%, 66.66%, and 100%. It may be concluded that Pathya Apathya, combined with a selected treatment modality, is a secure and reliable treatment for VÄ tarakta.

Date: 2023
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.rsisinternational.org/journals/ijrsi/d ... issue-11/311-318.pdf (application/pdf)
https://rsisinternational.org/journals/ijrsi/artic ... kta-gouty-arthritis/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bjc:journl:v:10:y:2023:i:11:p:311-318

Access Statistics for this article

International Journal of Research and Scientific Innovation is currently edited by Dr. Renu Malsaria

More articles in International Journal of Research and Scientific Innovation from International Journal of Research and Scientific Innovation (IJRSI)
Bibliographic data for series maintained by Dr. Renu Malsaria ().